Loading insider details...
Beta
Latest Form 4 (Oct 9, 2026): Purchase of 5,000 AGMB shares, $44.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | AgomAb Therapeutics NV (AGMB) | Purchase | 5,000 | $44.5K |
| Oct 7, 2026 | AgomAb Therapeutics NV (AGMB) | Purchase | 5,000 | $42.9K |
| Aug 5, 2026 | Tempus AI, Inc. (TEM) | Sale | 370 | $16.1K |
| Jun 3, 2026 | Tempus AI, Inc. (TEM) | Sale | 250 | $12.3K |
| May 27, 2026 | Tempus AI, Inc. (TEM) | Grant/Award | 5,913 | n/a |
| Mar 4, 2026 | Tempus AI, Inc. (TEM) | Sale | 250 | $12.7K |
| Feb 4, 2026 | Tempus AI, Inc. (TEM) | Sale | 370 | $22.0K |
| Dec 3, 2025 | Tempus AI, Inc. (TEM) | Sale | 250 | $18.9K |
| Nov 5, 2025 | Tempus AI, Inc. (TEM) | Sale | 370 | $33.3K |
| Sep 4, 2025 | Tempus AI, Inc. (TEM) | Sale | 250 | $18.4K |